Implantica

Implantica company information, Employees & Contact Information

Explore related pages

Related company profiles:

Implantica is a MedTech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

Company Details

Employees
57
Founded
-
Address
Industriestrasse 24, Zug,6300,switzerland
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Zug
Looking for a particular Implantica employee's phone or email?

Implantica Questions

News

Implantica presents the third quarter 2025 on October 31 at 15:00 CET - TradingView

Implantica presents the third quarter 2025 on October 31 at 15:00 CET TradingView

Implantica completes FDA 100-Day Meeting for RefluxStop® PMA application - TradingView

Implantica completes FDA 100-Day Meeting for RefluxStop® PMA application TradingView

Here's Why We're Not Too Worried About Implantica's (STO:IMP A SDB) Cash Burn Situation - simplywall.st

Here's Why We're Not Too Worried About Implantica's (STO:IMP A SDB) Cash Burn Situation simplywall.st

Could FDA Dialogue Mark a Turning Point in Implantica's (OM:IMP A SDB) U.S. Approval Strategy? - Yahoo Finance

Could FDA Dialogue Mark a Turning Point in Implantica's (OM:IMP A SDB) U.S. Approval Strategy? Yahoo Finance

Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback - Cision News

Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback Cision News

Implantica’s anti-reflux device shows positive two-year results - Clinical Trials Arena

Implantica’s anti-reflux device shows positive two-year results Clinical Trials Arena

Implantica reveals positive results for IEM implant - Medical Device Network

Implantica reveals positive results for IEM implant Medical Device Network

Performance Recap: How Implantica AG (Common Stock) (8IM1) stock stacks up against competitors - 2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Trung tâm Dự báo KTTV quốc gia

Performance Recap: How Implantica AG (Common Stock) (8IM1) stock stacks up against competitors - 2025 Fundamental Recap & AI Powered Buy and Sell Recommendations Trung tâm Dự báo KTTV quốc gia

Could FDA Feedback on RefluxStop Shape Implantica's US Ambitions and Long-Term Strategy (OM:IMP A SDB)? - simplywall.st

Could FDA Feedback on RefluxStop Shape Implantica's US Ambitions and Long-Term Strategy (OM:IMP A SDB)? simplywall.st

Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS) - Cision News

Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS) Cision News

Implantica gears up for FDA approval of acid reflux device - Medical Device Network

Implantica gears up for FDA approval of acid reflux device Medical Device Network

Will Implantica AG (Common Stock) (8IM1) stock outperform energy sector in 2025 - 2025 Market Sentiment & Community Verified Trade Alerts - Trung tâm Dự báo KTTV quốc gia

Will Implantica AG (Common Stock) (8IM1) stock outperform energy sector in 2025 - 2025 Market Sentiment & Community Verified Trade Alerts Trung tâm Dự báo KTTV quốc gia

Implantica Completes Critical 100-Day Meeting with FDA - MarketScreener

Implantica Completes Critical 100-Day Meeting with FDA MarketScreener

A Look at Implantica (OM:IMP A SDB) Valuation Following FDA 100-Day Meeting Milestone for RefluxStop® - simplywall.st

A Look at Implantica (OM:IMP A SDB) Valuation Following FDA 100-Day Meeting Milestone for RefluxStop® simplywall.st

Implantica’s RefluxStop™ procedure now available in Norway - Cision News

Implantica’s RefluxStop™ procedure now available in Norway Cision News

Implantica Renews International Certifications Following Successful Audit - MarketScreener

Implantica Renews International Certifications Following Successful Audit MarketScreener

Implantica adds another RefluxStop™ center in Spain - Cision News

Implantica adds another RefluxStop™ center in Spain Cision News

Implantica Further Expands its Commercial Footprint in Italy - Cision News

Implantica Further Expands its Commercial Footprint in Italy Cision News

Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society - Cision News

Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society Cision News

Pareto Raises Target Price for Implantica as FDA Approval Nears Turning Point - MarketScreener

Pareto Raises Target Price for Implantica as FDA Approval Nears Turning Point MarketScreener

ST Suzu Wu's stock price falls below 1 yuan, nearing delisting; Implantica responds to arbitration concerning Aesthetics|Quick Announcement - 富途牛牛

ST Suzu Wu's stock price falls below 1 yuan, nearing delisting; Implantica responds to arbitration concerning Aesthetics|Quick Announcement 富途牛牛

Implantica announces Spire Manchester Hospital in UK begins operating with RefluxStop™ - Cision News

Implantica announces Spire Manchester Hospital in UK begins operating with RefluxStop™ Cision News

Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™ - PR Newswire Canada

Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™ PR Newswire Canada

Top Implantica Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant